eMedicine Specialties > Pediatrics: General Medicine > Allergy & Immunology

Severe Combined Immunodeficiency: Multimedia

Author: Robert A Schwartz, MD, MPH, Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Coauthor(s): Smeeta Sinha, MD, Staff Physician, Department of Dermatology, UMDNJ-New Jersey Medical School
Contributor Information and Disclosures

Updated: Aug 18, 2009

Multimedia

This patient presented with fever and paralysis o...
(Enlarge Image)
Media file 1: This patient presented with fever and paralysis of his left arm 3 months after receiving his third oral poliovirus vaccine. Past history included chronic thrush presenting in the absence of antibiotic therapy or breastfeeding at 2 months, chronic diarrhea from 4 months, and recurrent otitis media. He was at the 90th percentile for height and weight, similar to his parents. Major histocompatibility complex (MHC) class II deficiency was diagnosed by immunologic tests.
[ CLOSE WINDOW ]
This patient presented with fever and paralysis o...

This patient presented with fever and paralysis of his left arm 3 months after receiving his third oral poliovirus vaccine. Past history included chronic thrush presenting in the absence of antibiotic therapy or breastfeeding at 2 months, chronic diarrhea from 4 months, and recurrent otitis media. He was at the 90th percentile for height and weight, similar to his parents. Major histocompatibility complex (MHC) class II deficiency was diagnosed by immunologic tests.

This patient with an autosomal recessive type of ...
(Enlarge Image)
Media file 2: This patient with an autosomal recessive type of severe combined immunodeficiency died of cytomegalovirus pneumonia when aged 22 months after prior infections that included recurrent otitis, pneumonia, and oral thrush. A CMV inclusion body is pictured in the upper left of the photo.
[ CLOSE WINDOW ]
This patient with an autosomal recessive type of ...

This patient with an autosomal recessive type of severe combined immunodeficiency died of cytomegalovirus pneumonia when aged 22 months after prior infections that included recurrent otitis, pneumonia, and oral thrush. A CMV inclusion body is pictured in the upper left of the photo.

Histologically, the thymus in severe combined imm...
(Enlarge Image)
Media file 3: Histologically, the thymus in severe combined immunodeficiency usually lacks Hassall corpuscles and is depleted of lymphocytes. In this photo, a Hassall corpuscle is identified to the right of center.
[ CLOSE WINDOW ]
Histologically, the thymus in severe combined imm...

Histologically, the thymus in severe combined immunodeficiency usually lacks Hassall corpuscles and is depleted of lymphocytes. In this photo, a Hassall corpuscle is identified to the right of center.

More on Severe Combined Immunodeficiency

Overview: Severe Combined Immunodeficiency
Differential Diagnoses & Workup: Severe Combined Immunodeficiency
Treatment & Medication: Severe Combined Immunodeficiency
Follow-up: Severe Combined Immunodeficiency
Multimedia: Severe Combined Immunodeficiency
References
[ CLOSE WINDOW ]

References

  1. Pannicke U, Hönig M, Hess I, Friesen C, Holzmann K, Rump EM. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nat Genet. Jan 2009;41(1):101-5. [Medline].

  2. Jimenez-Puya R, Vazquez-Bayo C, Rodriguez-Bujaldon A, Gomez Garcia F, Moreno-Gimenez JC. Extensive tinea in a patient with severe combined immunodeficiency. Pediatr Dermatol. Mar-Apr 2009;26(2):213-4. [Medline].

  3. Somech R, Roifman CM. Mutation analysis should be performed to rule out gammac deficiency in children with functional severe combined immune deficiency despite apparently normal immunologic tests. J Pediatr. Oct 2005;147(4):555-7. [Medline].

  4. Puck JM, Malech HL. Gene therapy for immune disorders: good news tempered by bad news. J Allergy Clin Immunol. Apr 2006;117(4):865-9. [Medline].

  5. Garcia-Lloret M, McGhee S, Chatila TA. Immunoglobulin replacement therapy in children. Immunol Allergy Clin North Am. Nov 2008;28(4):833-49, ix. [Medline].

  6. Hooper JA. Intravenous immunoglobulins: evolution of commercial IVIG preparations. Immunol Allergy Clin North Am. Nov 2008;28(4):765-78, viii. [Medline].

  7. Shah S. Pharmacy considerations for the use of IGIV therapy. Am J Health Syst Pharm. Aug 15 2005;62(16 Suppl 3):S5-11. [Medline].

  8. Siegel J. The product: all intravenous immunoglobuins are not equivalent. Pharmacotherapy. 2005;25(11 Pt 2):78S-84S.

  9. Neven B, Leroy S, Decaluwe H, et al. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood. Apr 23 2009;113(17):4114-24. [Medline].

  10. Bonilla FA, Geha RS. 2. Update on primary immunodeficiency diseases. J Allergy Clin Immunol. Feb 2006;117(2 Suppl Mini-Primer):S435-41. [Medline].

  11. Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol. 2004;22:625-55. [Medline].

  12. Buckley RH. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med. Nov 2 2000;343(18):1313-24. [Medline].

  13. Buckley RH. The multiple causes of human SCID. J Clin Invest. Nov 2004;114(10):1409-11. [Medline].

  14. Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. Feb 18 1999;340(7):508-16. [Medline].

  15. Candotti F, Villa A, Notarangelo LD. Severe combined immunodeficiency due to defects of JAK3 tyrosine kinase. In: Ochs HD, Smith CIE, Puck JM, eds. Primary Immunodeficiency Diseases. 1999:111-20.

  16. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. Apr 28 2000;288(5466):669-72. [Medline].

  17. Cunningham-Rundles C, Ponda PP. Molecular defects in T- and B-cell primary immunodeficiency diseases. Nat Rev Immunol. Nov 2005;5(11):880-92. [Medline].

  18. De Raeve L, Song M, Levy J. Cutaneous lesions as a clue to severe combined immunodeficiency. Pediatr Dermatol. Mar 1992;9(1):49-51. [Medline].

  19. Elder ME, Weiss A. SCID resulting from mutations in the gene encoding the protein tyrosine kinase ZAP-70. In: Ochs HD, Smith CIE, Puck JM, eds. Primary Immunodeficiency Diseases. 1999:146-54.

  20. Fischer A, de Saint Basile G, Le Deist F. CD3 deficiencies. Curr Opin Allergy Clin Immunol. Dec 2005;5(6):491-5. [Medline].

  21. Fischer A, Le Deist F, Hacein-Bey-Abina S. Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol Rev. Feb 2005;203:98-109. [Medline].

  22. Grunebaum E, Zhang J, Dadi H, Roifman CM. Haemophagocytic lymphohistiocytosis in X-linked severe combined immunodeficiency. Br J Haematol. Mar 2000;108(4):834-7. [Medline].

  23. Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med. Apr 18 2002;346(16):1185-93. [Medline].

  24. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. Jan 16 2003;348(3):255-6. [Medline].

  25. Haddad E, Landais P, Friedrich W, et al. Long-term immune reconstitution and outcome after HLA-nonidentical T- cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood. May 15 1998;91(10):3646-53. [Medline].

  26. Hirschhorn R. Immunodeficiency disease due to deficiency of adenosine deaminase. In: Ochs HD, Smith CIE, Puck JM, eds. Primary Immunodeficiency Diseases. 1999:121-39.

  27. Kalman L, Lindegren ML, Kobrynski L. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Genet Med. Jan-Feb 2004;6(1):16-26. [Medline].

  28. Makitie O, Kaitila I. Cartilage-hair hypoplasia--clinical manifestations in 108 Finnish patients. Eur J Pediatr. Mar 1993;152(3):211-7. [Medline].

  29. Moshous D, Callebaut I, de Chasseval R, et al. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell. Apr 20 2001;105(2):177-86. [Medline].

  30. Muench MO. In utero transplantation: baby steps towards an effective therapy. Bone Marrow Transplant. Mar 2005;35(6):537-47. [Medline].

  31. Nicolas N, Finnie NJ, Cavazzana-Calvo M, et al. Lack of detectable defect in DNA double-strand break repair and DNA- dependent protein kinase activity in radiosensitive human severe combined immunodeficiency fibroblasts. Eur J Immunol. May 1996;26(5):1118-22. [Medline].

  32. Notarangelo L, Casanova JL, Fischer A. Primary immunodeficiency diseases: an update. J Allergy Clin Immunol. Sep 2004;114(3):677-87. [Medline].

  33. Puck JM. X-linked severe combined immunodeficiency. In: Ochs HD, Smith CIE, Puck JM, eds. Primary Immunodeficiency Diseases. 1999:99-110.

  34. Roifman CM, Zhang J, Chitayat D, Sharfe N. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood. Oct 15 2000;96(8):2803-7. [Medline].

  35. Saleem MA, Arkwright PD, Davies EG. Clinical course of patients with major histocompatibility complex class II deficiency. Arch Dis Child. Oct 2000;83(4):356-9. [Medline].

  36. Zonana J, Elder ME, Schneider LC, et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet. Dec 2000;67(6):1555-62. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

severe combined immunodeficiency, SCID, X-linked SCID, XL-SCID, MHC class II deficiency, bare lymphocyte syndrome, adenosine deaminase–deficient SCID, ADA-deficient SCID, recurrent infections, failure to thrive, dermatitis, bone marrow transplantation, DiGeorge syndrome, CHARGE syndrome, hematopoietic stem cell transplantation, HSCT, otitis media, cytomegalovirus infection, CMV, varicella, respiratory syncytial virus, RSV, rotavirus, parainfluenza virus, Epstein-Barr virus, EBV, enterovirus, adenovirus, non-Hodgkin lymphoma, herpes simplex virus, cryptosporidiosis, Crohn disease, HIV infection, graft versus host disease, GVHD, Omenn syndrome, treatment, diagnosis

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Robert A Schwartz, MD, MPH, Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi
Disclosure: Nothing to disclose.

Coauthor(s)

Smeeta Sinha, MD, Staff Physician, Department of Dermatology, UMDNJ-New Jersey Medical School
Smeeta Sinha, MD is a member of the following medical societies: Alpha Omega Alpha, Phi Beta Kappa, and Sigma Xi
Disclosure: Nothing to disclose.

Medical Editor

James M Oleske, MD, MPH, François-Xavier Bagnoud Professor of Pediatrics, Director, Division of Pulmonary, Allergy, Immunology and Infectious Diseases, Department of Pediatrics, New Jersey Medical School
James M Oleske, MD, MPH is a member of the following medical societies: Academy of Medicine of New Jersey, American Academy of Pediatrics, American Public Health Association, American Society for Microbiology, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

David J Valacer, MD, Consulting Staff, Hoffman La Roche Pharmaceuticals
David J Valacer, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, American Association for the Advancement of Science, American Thoracic Society, and New York Academy of Sciences
Disclosure: Nothing to disclose.

CME Editor

David Pallares, MD, Clinical Assistant Professor, Department of Pediatrics, Division of Allergy and Immunology, University of Louisville
David Pallares, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology
Disclosure: Nothing to disclose.

Chief Editor

Harumi Jyonouchi, MD, Associate Professor, Division of Pulmonary Allergy/Immunology and Infectious Diseases, Department of Pediatrics, UMDNJ-New Jersey Medical School
Harumi Jyonouchi, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, American Association of Immunologists, American Medical Association, Clinical Immunology Society, New York Academy of Sciences, Society for Experimental Biology and Medicine, Society for Mucosal Immunology, and Society for Pediatric Research
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.